MedTrace Logo

Costs, Health Status and Outcomes of CAP (Community-Acquired Pneumonia)

NCT00812084 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48634

Last updated 2015-06-12

No results posted yet for this study

Summary

The purpose of this study is to collect additional data on hospitalized Community-Acquired Pneumonia (CAP) on health states, health outcomes and on (health) resources and estimate the differences in the quality of life and resources of elderly persons with and without CAP.

Conditions

Sponsors & Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

    collaborator INDUSTRY

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • G.Ardine de Wit, PhD · Julius Center for Health Sciences and Primary Care; UMC Utrecht

  • Marc J.M. Bonten, Prof., MD PhD · Julius Center for Health Sciences and Primary Care; UMC Utrecht

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Netherlands

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00812084 on ClinicalTrials.gov